SAFEMed Reports: Ukraine’s Pharmaceutical Market Shows Resilience Amid War, with New Risks and Opportunities Emerging

Ukraine’s pharmaceutical market has undergone significant changes since the full-scale invasion in 2022. Two SAFEMed-supported market analyses trace this transformation, from the disruption caused by the war to the market’s recovery and the new pressures emerging in 2026.

Resilience and Recovery: Ukraine’s Pharmaceutical Market Amidst Crisis (2017–2025) examines longer-term market trends, including changes in market structure, local manufacturing, public procurement, affordability, and pharmaceutical reforms. The report highlights the market’s ability to adapt to wartime disruption while identifying key risks and opportunities for its continued recovery.

The more recent Resilience Under Pressure: Ukraine’s Medicines Market, 2022–2026 brings the analysis up to 2026, examining market performance, pricing reforms, public financing, and supply-chain vulnerabilities. While the market remains resilient, the report identifies emerging pressure on household demand and opportunities to strengthen domestic production and attract investment.